
Website: www.patheon.com TORONTO, Nov. 16 /CNW/ - Patheon Inc. (TSX: PTI) today issued the following statement in response to recent trading activity. As previously announced on September 11, 2006, the Board of Patheon has established a special committee and engaged financial advisors to evaluate strategic and financial alternatives for the company. The company is in discussions with a number of parties with regard to various alternatives. There can be no assurance that a transaction or other material development will result from this process. No further announcements will be made by the company unless and until circumstances so warrant. Patheon (TSX:PTI; www.patheon.com) is a leading global provider of drug development and manufacturing services to the international pharmaceutical industry. Patheon operates a network of 14 facilities in the United States, Canada and Europe, employing more than 5,900 people and serving a client base of more than 200 pharmaceutical and biotechnology companies. %SEDAR: 00001700E